CTOs on the Move

KSQ Therapeutics

www.ksqtx.com

 
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ksqtx.com
  • 4 Maguire Road
    Lexington, MA USA 02421
  • Phone: 617.674.9150

Executives

Name Title Contact Details
Thomas Leitch
Chief Technology Officer Profile

Funding

KSQ Therapeutics raised $76M on 10/02/2017
KSQ Therapeutics raised $80M on 09/28/2018

Similar Companies

Laboratory Supply Co.

Laboratory Supply Company was founded by Charles (Charlie) Davis in Louisville, Kentucky in 1972. LABSCO has nine distribution centers and has grown to be the largest privately held distributor of clinical laboratory products in the United States. LABSCO is known for its expertise in the clinical laboratory, but is also a full line distributor of diagnostic systems and laboratory supplies to the physician office laboratory (POL) and other alternate care settings.

Towson Medical Equipment Co

Towson Medical Equipment Co is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Dosimetry Solutions (GDS)

Global Dosimetry Solutions, Inc. (GDS) is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.

GandH Wire Company

G&H Wire Company is a Greenwood, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.